-
1
-
-
0026683326
-
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event
-
De Clercq, E., N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, B.A. Murrer, D. Schwartz, D. Thomton, et al. 1992. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc. Natl. Acad. Sci. USA. 89:5286-5290.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 5286-5290
-
-
De Clercq, E.1
Yamamoto, N.2
Pauwels, R.3
Baba, M.4
Schols, D.5
Nakashima, H.6
Balzarini, J.7
Murrer, B.A.8
Schwartz, D.9
Thomton, D.10
-
2
-
-
0028209166
-
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100
-
De Clercq, E., N. Yamamoto, R. Pauwels, J. Balzarini, M. Witvrouw, K. De Vreese, Z. Debyser, B. Rosenwirth, P. Peichl, R. Datema, et al. 1994. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38:668-674.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 668-674
-
-
De Clercq, E.1
Yamamoto, N.2
Pauwels, R.3
Balzarini, J.4
Witvrouw, M.5
De Vreese, K.6
Debyser, Z.7
Rosenwirth, B.8
Peichl, P.9
Datema, R.10
-
3
-
-
0029939009
-
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding
-
De Vreese, K., D. Reymen, P. Griffin, A. Steinkasserer, G. Werner, G.J. Bridger, J. Esté, W. James, G. Henson, J. Desmyter, et al. 1996. The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antivir. Res. 29:209-219.
-
(1996)
Antivir. Res.
, vol.29
, pp. 209-219
-
-
De Vreese, K.1
Reymen, D.2
Griffin, P.3
Steinkasserer, A.4
Werner, G.5
Bridger, G.J.6
Esté, J.7
James, W.8
Henson, G.9
Desmyter, J.10
-
4
-
-
0003973947
-
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
-
De Vreese, K., V. Kofler-Mongold, C. Leutgeb, V. Weber, K. Vermeire, S. Schacht, J. Anné, E. De Clercq, R. Datema, and G. Werner. 1996. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol. 70:689-696.
-
(1996)
J. Virol.
, vol.70
, pp. 689-696
-
-
De Vreese, K.1
Kofler-Mongold, V.2
Leutgeb, C.3
Weber, V.4
Vermeire, K.5
Schacht, S.6
Anné, J.7
De Clercq, E.8
Datema, R.9
Werner, G.10
-
5
-
-
0030002637
-
HIV-1 entry cofector: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
-
Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofector: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (Wash. DC). 272:872-877.
-
(1996)
Science (Wash. DC)
, vol.272
, pp. 872-877
-
-
Feng, Y.1
Broder, C.C.2
Kennedy, P.E.3
Berger, E.A.4
-
6
-
-
0029821869
-
A seven-transmembrane domain receptor involved in fusion and entry of T cell-tropic human immunodeficiency virus type-1 strains
-
Berson, J.F., D. Long, B.J. Doranz, J. Rucker, F.R. Jirik, and R.W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T cell-tropic human immunodeficiency virus type-1 strains. J. Virol. 70:6288-6295.
-
(1996)
J. Virol.
, vol.70
, pp. 6288-6295
-
-
Berson, J.F.1
Long, D.2
Doranz, B.J.3
Rucker, J.4
Jirik, F.R.5
Doms, R.W.6
-
7
-
-
0029775576
-
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
-
Bleul, C.C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T.A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (Lond.). 382:829-832.
-
(1996)
Nature (Lond.)
, vol.382
, pp. 829-832
-
-
Bleul, C.C.1
Farzan, M.2
Choe, H.3
Parolin, C.4
Clark-Lewis, I.5
Sodroski, J.6
Springer, T.A.7
-
8
-
-
16044370087
-
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
-
Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.M. Heard, I. Clark-Lewis, D.F. Legler, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (Lond.). 382:833-835.
-
(1996)
Nature (Lond.)
, vol.382
, pp. 833-835
-
-
Oberlin, E.1
Amara, A.2
Bachelerie, F.3
Bessia, C.4
Virelizier, J.L.5
Arenzana-Seisdedos, F.6
Schwartz, O.7
Heard, J.M.8
Clark-Lewis, I.9
Legler, D.F.10
-
9
-
-
0030018156
-
CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
-
Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (Wash. DC). 272: 1955-1958.
-
(1996)
Science (Wash. DC)
, vol.272
, pp. 1955-1958
-
-
Alkhatib, G.1
Combadiere, C.2
Broder, C.C.3
Feng, Y.4
Kennedy, P.E.5
Murphy, P.M.6
Berger, E.A.7
-
10
-
-
0005014748
-
The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
-
Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
-
(1996)
Cell
, vol.85
, pp. 1135-1148
-
-
Choe, H.1
Farzan, M.2
Sun, Y.3
Sullivan, N.4
Rollins, B.5
Ponath, P.D.6
Wu, L.7
Mackay, C.R.8
LaRosa, G.9
Newman, W.10
-
11
-
-
15844419153
-
Identification of a major co-receptor for primary isolates of HIV-1
-
Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P.D. Marzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature (Lond.). 381:661-666.
-
(1996)
Nature (Lond.)
, vol.381
, pp. 661-666
-
-
Deng, H.1
Liu, R.2
Ellmeier, W.3
Choe, S.4
Unutmaz, D.5
Burkhart, M.6
Marzio, P.D.7
Marmon, S.8
Sutton, R.E.9
Hill, C.M.10
-
12
-
-
0030604727
-
A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
-
Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
-
(1996)
Cell
, vol.85
, pp. 1149-1158
-
-
Doranz, B.J.1
Rucker, J.2
Yi, Y.3
Smyth, R.J.4
Samson, M.5
Peiper, S.C.6
Parmentier, M.7
Collman, R.G.8
Doms, R.W.9
-
13
-
-
15844389650
-
+ cells is mediated by the chemokine receptor CC-CKR-5
-
+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (Lond.). 381:667-673.
-
(1996)
Nature (Lond.)
, vol.381
, pp. 667-673
-
-
Dragic, T.1
Litwin, V.2
Allaway, G.P.3
Martin, S.R.4
Huang, Y.5
Nagashima, K.A.6
Cayanan, C.7
Maddon, P.J.8
Koup, R.A.9
Moore, J.P.10
Paxton, W.A.11
-
15
-
-
16144365317
-
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
-
Trkola, A., T. Dragic, J. Arthos, J.M. Binley, W.C. Olson, G.P. Allaway, C. Cheng-Mayer, J. Robinson, P.J. Maddon, and J.P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature (Lond.). 384:184-187.
-
(1996)
Nature (Lond.)
, vol.384
, pp. 184-187
-
-
Trkola, A.1
Dragic, T.2
Arthos, J.3
Binley, J.M.4
Olson, W.C.5
Allaway, G.P.6
Cheng-Mayer, C.7
Robinson, J.8
Maddon, P.J.9
Moore, J.P.10
-
16
-
-
16144365650
-
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
-
Wu, L., N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (Lond.). 384:179-183.
-
(1996)
Nature (Lond.)
, vol.384
, pp. 179-183
-
-
Wu, L.1
Gerard, N.P.2
Wyatt, R.3
Choe, H.4
Parolin, C.5
Ruffing, N.6
Borsetti, A.7
Cardoso, A.A.8
Desjardin, E.9
Newman, W.10
-
17
-
-
0026721539
-
Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family
-
Van Damme, J., P. Proost, J.-P. Lenaerts, and G. Opdenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:59-65.
-
(1992)
J. Exp. Med.
, vol.176
, pp. 59-65
-
-
Van Damme, J.1
Proost, P.2
Lenaerts, J.-P.3
Opdenakker, G.4
-
18
-
-
0345196609
-
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor
-
Schols, D., R. Pauwels, M. Baba, J. Desmyter, and E. De Clercq 1989. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA. 86:3322-3326.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 3322-3326
-
-
Schols, D.1
Pauwels, R.2
Baba, M.3
Desmyter, J.4
De Clercq, E.5
-
19
-
-
0031017657
-
Characterization of synthetic human granulocyte chemotactic protein 2: Usage of chemokine receptors CXCR1 and CXCR2 and in vivo imflammatory properties
-
Wuyts, A., N. Van Osselaer, A. Haelens, I. Samson, P. Herdewijn, A. Ben-Baruch, J.J. Oppenheim, P. Proost, and J. Van Damme. 1997. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo imflammatory properties. Biochemistry. 36:2716-2723.
-
(1997)
Biochemistry
, vol.36
, pp. 2716-2723
-
-
Wuyts, A.1
Van Osselaer, N.2
Haelens, A.3
Samson, I.4
Herdewijn, P.5
Ben-Baruch, A.6
Oppenheim, J.J.7
Proost, P.8
Van Damme, J.9
-
20
-
-
0028845090
-
Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist
-
Masure, S., L. Paemen, P. Proost, J. Van Damme, and G. Opdenakker. 1995. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist. J. Interferon Cytokine Res. 15: 955-963.
-
(1995)
J. Interferon Cytokine Res.
, vol.15
, pp. 955-963
-
-
Masure, S.1
Paemen, L.2
Proost, P.3
Van Damme, J.4
Opdenakker, G.5
-
21
-
-
1842371216
-
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
-
Edinger, A.L., A. Amedee, K. Miller, B.J. Doranz, M. Endres, M. Sharron, M. Samson, Z.-H. Lu, J.E. Clements, M. Murphy-Corb, et al. 1997. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA. 94:4005-4010.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 4005-4010
-
-
Edinger, A.L.1
Amedee, A.2
Miller, K.3
Doranz, B.J.4
Endres, M.5
Sharron, M.6
Samson, M.7
Lu, Z.-H.8
Clements, J.E.9
Murphy-Corb, M.10
-
22
-
-
16144365390
-
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
-
Endres, M.J., P.R. Clapham, M. Marsh, M. Ahuja, J.D. Turner, A. McKnight, J.F. Thomas, B. Stoebenau-Haggarty, S. Choe, P.J. Vance, et al. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:745-756.
-
(1996)
Cell
, vol.87
, pp. 745-756
-
-
Endres, M.J.1
Clapham, P.R.2
Marsh, M.3
Ahuja, M.4
Turner, J.D.5
McKnight, A.6
Thomas, J.F.7
Stoebenau-Haggarty, B.8
Choe, S.9
Vance, P.J.10
-
23
-
-
0031024664
-
Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
-
McKnight, A., D. Wilkinson, G. Simmons, S. Talbot, L. Picard, M. Ahuja, M. Marsh, J.A. Hoxie, and P.R. Clapham. 1997. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1692-1696.
-
(1997)
J. Virol.
, vol.71
, pp. 1692-1696
-
-
McKnight, A.1
Wilkinson, D.2
Simmons, G.3
Talbot, S.4
Picard, L.5
Ahuja, M.6
Marsh, M.7
Hoxie, J.A.8
Clapham, P.R.9
-
24
-
-
0029833943
-
A highly efficacious lymphocyte chemoattractant stromal cell-derived factor 1 (SDF-1)
-
Bleul, C.C., R.C. Fuhlbrigge, J.M. Casasnovas, A. Aiuti, and T.A. Springer. 1996. A highly efficacious lymphocyte chemoattractant stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101-1109.
-
(1996)
J. Exp. Med.
, vol.184
, pp. 1101-1109
-
-
Bleul, C.C.1
Fuhlbrigge, R.C.2
Casasnovas, J.M.3
Aiuti, A.4
Springer, T.A.5
-
25
-
-
0029562205
-
Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2b
-
Combadiere, C., S.K. Ahuja, J. Van Damme, H.L. Tiffany, J.-L. Gao, and P.M. Murphy. 1995. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2b. J. Biol. Chem. 270:29671-29675.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 29671-29675
-
-
Combadiere, C.1
Ahuja J, S.K.2
Van Damme3
Tiffany, H.L.4
Gao, J.-L.5
Murphy, P.M.6
-
26
-
-
0029976181
-
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM3100), an inhibitor of infectious cell entry
-
Datema, R., L. Rabin, M. Hincenbergs, M.B. Moreno, S. Warren, V. Linquist, B. Rosenwirth, J. Seifert, and J.M. McCune. 1996. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM3100), an inhibitor of infectious cell entry. Antimicrob. Agents Chemother. 40:750-754.
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 750-754
-
-
Datema, R.1
Rabin, L.2
Hincenbergs, M.3
Moreno, M.B.4
Warren, S.5
Linquist, V.6
Rosenwirth, B.7
Seifert, J.8
McCune, J.M.9
-
27
-
-
0001633495
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
-
Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science (Wash. DC). 273:1856-1862.
-
(1996)
Science (Wash. DC)
, vol.273
, pp. 1856-1862
-
-
Dean, M.1
Carrington, M.2
Winkler, C.3
Huttley, G.A.4
Smith, M.W.5
Allikmets, R.6
Goedert, J.J.7
Buchbinder, S.P.8
Vittinghoff, E.9
Gomperts, E.10
-
28
-
-
15844388931
-
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
-
Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
-
(1996)
Cell
, vol.86
, pp. 367-377
-
-
Liu, R.1
Paxton, W.A.2
Choe, S.3
Ceradini, D.4
Martin, S.R.5
Horuk, R.6
MacDonald, M.E.7
Stuhlmann, H.8
Koup, R.A.9
Landau, N.R.10
-
29
-
-
16044373004
-
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
-
Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.-M. Farber, S. Saragosti, C. Lapouméroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (Lond.). 382:722-725.
-
(1996)
Nature (Lond.)
, vol.382
, pp. 722-725
-
-
Samson, M.1
Libert, F.2
Doranz, B.J.3
Rucker, J.4
Liesnard, C.5
Farber, C.-M.6
Saragosti, S.7
Lapouméroulie, C.8
Cognaux, J.9
Forceille, C.10
-
30
-
-
0026600926
-
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
-
Schuitemaker, H., M. Koot, N.A. Kootstra, M.W. Dercksen, R.E. de Goede, R.P. van Steenwijk, J.M. Lange, J.K. Schattenkerk, F. Miedema, and M. Tersmette. 1994. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-1360.
-
(1994)
J. Virol.
, vol.66
, pp. 1354-1360
-
-
Schuitemaker, H.1
Koot, M.2
Kootstra, N.A.3
Dercksen, M.W.4
De Goede, R.E.5
Van Steenwijk, R.P.6
Lange, J.M.7
Schattenkerk, J.K.8
Miedema, F.9
Tersmette, M.10
-
31
-
-
0031575431
-
Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
-
Connor, R.I., K.E. Sheridan, D. Ceradini, S. Choe, and N.R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-628.
-
(1997)
J. Exp. Med.
, vol.185
, pp. 621-628
-
-
Connor, R.I.1
Sheridan, K.E.2
Ceradini, D.3
Choe, S.4
Landau, N.R.5
-
32
-
-
16044370301
-
HIV blocked by chemokine antagonist
-
Arenzana-Seisdedos, F., J.-L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature (Lond.). 383:400.
-
(1996)
Nature (Lond.)
, vol.383
, pp. 400
-
-
Arenzana-Seisdedos, F.1
Virelizier, J.-L.2
Rousset, D.3
Clark-Lewis, I.4
Loetscher, P.5
Moser, B.6
Baggiolini, M.7
-
33
-
-
0030951442
-
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
-
Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, T.W. Schwartz, R. Buser, T.N.C. Wells, and A.E.I. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (Wash. DC). 276:276-279.
-
(1997)
Science (Wash. DC)
, vol.276
, pp. 276-279
-
-
Simmons, G.1
Clapham, P.R.2
Picard, L.3
Offord, R.E.4
Rosenkilde, M.M.5
Schwartz, T.W.6
Buser, R.7
Wells, T.N.C.8
Proudfoot, A.E.I.9
|